propranolol has been researched along with Central Nervous System Diseases in 14 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Clinically, propranolol, an agent of this group, has been investigated in the treatment of various clinical disorders including schizophrenia, other psychoses, anxiety disorders, and stress reactions." | 6.15 | Propranolol in psychiatry. Therapeutic uses and side effects. ( Ananth, J; Lin, KM, 1986) |
| "This child developed significant acute dilated cardiomyopathy and severe CNS depression 2 hours after ingesting 3200 mg of propranolol." | 1.30 | Acute dilated cardiomyopathy and central nervous system toxicity following propranolol intoxication. ( Lifshitz, M; Zalzstein, E; Zucker, N, 1999) |
| "In talinolol were in the first place dysrhythmias, hypotension and vomiting and nausea, respectively, in propranolol central-nervous symptoms and hypotension." | 1.27 | [Acute beta blocker poisoning]. ( Haustein, KO; Knappe, J; Kulick, B; Oltmanns, G; Schmidt, H; Schwela, H, 1985) |
| "The hypotension was not affected by pretreatment with propranolol." | 1.27 | Insulin-induced hypotension and neurogenic orthostatic hypotension. ( Brown, RT; Deeter, JA; Lee, GK; Polinsky, RJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (71.43) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Shabrawi, M | 1 |
| Hassanin, F | 1 |
| Taylor, EA | 1 |
| Jefferson, D | 1 |
| Carroll, JD | 1 |
| Turner, P | 1 |
| Hale, WE | 1 |
| Stewart, RB | 1 |
| Marks, RG | 1 |
| Lifshitz, M | 1 |
| Zucker, N | 1 |
| Zalzstein, E | 1 |
| Conway, J | 1 |
| Greenwood, DT | 1 |
| Middlemiss, DN | 1 |
| Frishman, W | 1 |
| Silverman, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Dahlöf, C | 1 |
| Kostis, JB | 1 |
| Rosen, RC | 1 |
| Holzer, BC | 1 |
| Randolph, C | 1 |
| Taska, LS | 1 |
| Miller, MH | 1 |
| Conant, J | 1 |
| Engler, R | 1 |
| Janowsky, D | 1 |
| Maisel, A | 1 |
| Gilpin, E | 1 |
| LeWinter, M | 1 |
| Oltmanns, G | 1 |
| Schwela, H | 1 |
| Kulick, B | 1 |
| Knappe, J | 1 |
| Haustein, KO | 1 |
| Schmidt, H | 1 |
| Ananth, J | 1 |
| Lin, KM | 1 |
| Brown, RT | 1 |
| Polinsky, RJ | 1 |
| Lee, GK | 1 |
| Deeter, JA | 1 |
| Watanabe, T | 1 |
| Matsuhashi, K | 1 |
| Takayama, S | 1 |
| Imura, H | 1 |
| Nakai, Y | 1 |
| Matsukura, S | 1 |
| Matsuyama, H | 1 |
3 reviews available for propranolol and Central Nervous System Diseases
| Article | Year |
|---|---|
Propranolol safety profile in children.
Topics: Adrenergic beta-Antagonists; Age Factors; Angina Pectoris; Central Nervous System Diseases; Child; D | 2011 |
Central nervous actions of beta-adrenoreceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Behavior; Central Nervous System; Central Nervous Sys | 1978 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
3 trials available for propranolol and Central Nervous System Diseases
| Article | Year |
|---|---|
CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males.
Topics: Adult; Affect; Aged; Antihypertensive Agents; Central Nervous System Diseases; Clonidine; Cognition; | 1990 |
Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility.
Topics: Adult; Affect; Aged; Atenolol; Central Nervous System Diseases; Humans; Lipids; Male; Middle Aged; M | 1989 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
9 other studies available for propranolol and Central Nervous System Diseases
| Article | Year |
|---|---|
Cerebrospinal fluid concentrations of propranolol, pindolol and atenolol in man: evidence for central actions of beta-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Central Nervous System; Central Nervous System D | 1981 |
Central nervous system symptoms of elderly subjects using antihypertensive drugs.
Topics: Aged; Antihypertensive Agents; Central Nervous System Diseases; Diuretics; Dizziness; Drug Combinati | 1984 |
Acute dilated cardiomyopathy and central nervous system toxicity following propranolol intoxication.
Topics: Acute Disease; Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antidotes; Cardiom | 1999 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Minor Symptoms Evaluation (MSE) Profile--a questionnaire for assessment of subjective CNS-related symptoms.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzodiazepines; Central Nervous System Diseas | 1990 |
[Acute beta blocker poisoning].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Alcohol Drinking; Cardiovascular Diseases; Central N | 1985 |
Insulin-induced hypotension and neurogenic orthostatic hypotension.
Topics: Aged; Blood Glucose; Blood Pressure; Central Nervous System Diseases; Epinephrine; Female; Heart Rat | 1986 |
[Study on the postnatal neuro-behavioral development in rats treated prenatally with drugs acting on the autonomic nervous systems].
Topics: Animals; Atropine; Autonomic Agents; Central Nervous System Diseases; Chlorpromazine; Epinephrine; F | 1985 |
Effect of intravenous infusion of L-DOPA on plasma growth hormone levels in man.
Topics: Adult; Aged; Anorexia Nervosa; Blood Glucose; Central Nervous System Diseases; Dihydroxyphenylalanin | 1973 |